국내 1위 제약사 자리를 굳혀온 유한양행은 1분기 매출이 3133억원에 그쳐 셀트리온에 1위 자리를 내줬다.
Yuhan Corp., which has solidified its position as the nation's No. 1 pharmaceutical company, gave up its No. 1 position to Celltrion with sales of only 313.3 billion won in the first quarter.